The kidney and cardiovascular outcome trials
Author:
Affiliation:
1. Icahn School of Medicine at Mount Sinai; New York USA
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12616/fullpdf
Reference21 articles.
1. Understanding CKD among patients with T2DM: Prevalence, temporal trends, and treatment patterns - NHANES 2007-2012;Wu;BMJ Open Diabetes Res Care,2016
2. Sodium-glucose cotransporter 2 inhibitors and renal function-2;Bloomgarden;J Diabetes,2015
3. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial;Ismail-Beigi;Lancet,2010
4. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial;Zoungas;Diabetes Care,2009
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of DPP-4i inhibitors on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials;Lipids in Health and Disease;2024-05-25
2. Acute kidney injury, renal impairment and renal failure associated with sodium glucose co‐transporter‐2 inhibitors in at‐risk groups: A systematic review;British Journal of Clinical Pharmacology;2024-05-24
3. Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks;Archives of Pharmacy and Pharmaceutical Sciences;2024-05-02
4. Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease;Biomedicines;2024-03-14
5. Sepsis associated with sodium glucose co‐transporter 2 inhibitor in an elderly patient with chronic kidney disease;Geriatrics & Gerontology International;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3